Ultrasound-enhanced transcorneal drug delivery

Cornea

Volumn 23, Issue 8, 2004, Pages 804-811

  Zderic, Vesna ^a,b,c   Clark, John I ^b   Martin, Roy W ^a,b   Vaezy, Shahram ^a,b  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Center for Industrial and Medical Ultrasound   (United States)

Author keywords

Cornea; Drug delivery; Phonophoresis; Sonophoresis; Ultrasound

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARTEOLOL; FLUORESCEIN SODIUM; TIMOLOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL SWELLING; COLOR; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA PERMEABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; IMAGE ENHANCEMENT; IN VIVO STUDY; INTRAOCULAR DRUG ADMINISTRATION; MEMBRANE RUPTURE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETRY; TRANSCORNEAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND;

ANIMALS; CONTRAST MEDIA; CORNEA; DRUG DELIVERY SYSTEMS; FLUORESCEIN; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; PERMEABILITY; PHONOPHORESIS; RABBITS; ULTRASONICS;

EID: 7444246137     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000134189.33549.cc     Document Type: Article

References (55)

1. Ke TL, Clark AF, Gracy RW. Age-related permeability changes in rabbit corneas. J Ocul Pharmacol Ther. 1999;15:513-523.
2. Davies NM. Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol. 2000;27:558-562.
3. Doane MG, Jensen AD, Dohlman CH. Penetration routes of topically applied eye medications. Am J Ophthalmol. 1978;85:383-386.
4. Lee VH. New directions in the optimization of ocular drug delivery. J Ocul Pharmacol. 1990;6:157-164.
5. Sasaki H, Ichikawa M, Kawakami S, et al. In situ ocular absorption of tilisolol through ocular membranes in albino rabbits. J Pharm Sci. 1996;85:940-943.
6. Raviola G. The structural basis of the blood-ocular barriers. Exp Eye Res. 1977;25(Suppl):27-63.
7. Sasaki H, Yamamura K, Mukai T, et al. Enhancement of ocular drug penetration. Crit Rev Ther Drug Carrier Syst. 1999;16:85-146.
8. Mitragotri S, Blankschtein D, Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm Res. 1996;13:411-420.
9. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science. 1995;269:850-853.
10. Zderic V, Vaezy S, Martin RW, et al. Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med Biol. 2002;28:823-829.
11. Patel GM, Chuang AZ, Kiang E, et al. Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. J Cataract Refract Surg. 2000;26:690-694.
12. Egorov EA, Kriukova MB, Khabush T, et al. Results of intraocular pharmaco-physical therapy in inflammatory diseases of the cornea. Vestn Oftalmol. 1995;111:31-34.
13. Marmur RK, Moiseeva NN, Korkhov SS. Current state and perspectives of further development of phonophoresis of drugs in ophthalmology (review of the literature). Oftalmol Zh. 1979;34:68-73.
14. Iakimenko SA, Chalanova RI. Phonophoresis of the proteolytic enzymes lekozim or kollalizin in the combined therapy of eye bums. Oftalmol Zh. 1990;6:321-324.
15. Iakimenko SA, Chalanova RI, Artemov AV. The use of lekozim phonophoresis for the treatment of eye bums. Oftalmol Zh. 1989;8:492-497.
16. Tsok RM. Phonophoresis in various diseases of the anterior segment of the eye. Oftalmol Zh. 1979;34:73-76.
17. Gvarishvili EP, Dushin NV. Effect of superphonoelectrophoresis on chorioretinal dystrophy. Vestn Oftalmol. 1999;115:19-21.
18. Tsok RM, Gereliuk IP, Tsok OB, et al. The effect of ultrasonic oscillations of different frequencies on radionuclide accumulation in the eye tissues. Oftalmol Zh. 1990;1:46-49.
19. Nuritdinov VA. Phonophoresis and cavitation. Vestn Oftalmol. 1981;1:56-58.
20. Panova IG, Fateeva VI, Petrishcheva TS, et al. A pharmacokinetic study of para-aminobenzoic acid administered into the rabbit eye by phonophoresis. Izv Akad Nauk Ser Biol 1995;4:487-489.
21. Saito K, Miyake K, McNeil PL, et al. Plasma membrane disruption underlies injury of the corneal endothelium by ultrasound. Exp Eye Res. 1999;68:431-437.
22. Rutzen AR, Roberts CW, Driller J, et al. Production of corneal lesions using high-intensity focused ultrasound. Cornea. 1990;9:324-330.
23. Tak RV, Pal D, Gao H, et al. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. J Pharm Sci. 2001;90:1505-1515.
24. Christensen DA. Chapter 8. In: Ultrasonic Bioinstrumentation. John Wiley and Sons, 1988:218-220.
25. Abbott JG. Rationale and derivation of MI and TI - a review. Ultrasound Med Biol. 1999;25:431-441.
26. Ahmed I, Gokhale RD, Shah MV, et al. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J Pharm Sci. 1987;76:583-586.
27. Araie M, Maurice D. The rate of diffusion of fluorophores through the corneal epithelium and stroma. Exp Eye Res. 1987;44:73-87.
28. Karnovsky M. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol. 1965;27:137A.
29. Grass GM, Robinson JR. Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement. J Pharm Sci. 1988;77:15-23.
30. Abe H, Kuroki M, Tachibana K, et al. Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res. 2002;22:1575-1580.
31. Lawrie A, Brisken AF, Francis SE, et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation. 1999;99:2617-2620.
32. Miller MW. Gene transfection and drug delivery. Ultrasound Med Biol. 2000;26(Suppl 1):S59-S62.
33. Tachibana K, Tachibana S. The use of ultrasound for drug delivery. Echocardiography. 2001;18:323-328.
34. Tang H, Mitragotri S, Blankschtein D, et al. Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. J Pharm Sci. 2001;90:545-568.
35. Leighton TG. The Acoustic Bubble. San Diego: Academic Press, 1994.
36. Guzman HR, Nguyen DX, McNamara AJ, et al. Equilibrium loading of cells with macromolecules by ultrasound: effects of molecular size and acoustic energy. J Pharm Sci. 2002;91:1693-1701.
37. Liu J, Lewis TN, Prausnitz MR. Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res. 1998;15:918-924.
38. Miller DL. A review of the ultrasonic bioeffects of microsonation, gas-body activation, and related cavitation-like phenomena. Ultrasound Med Biol. 1987;13:443-470.
39. Tang H, Wang CC, Blankschtein D, et al. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res. 2002;19:1160-1169.
40. Frenkel V, Kimmel E, Iger Y. Ultrasound-induced cavitation damage to external epithelia of fish skin. Ultrasound Med Biol. 1999;25:1295-1303.
41. Ban Y, Dota A, Cooper LJ, et al. Tight junction-related protein expression and distribution in human corneal epithelium. Exp Eye Res. 2003;76:663-669.
42. Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
43. Mitragotri S, Edwards DA, Blankschtein D, et al. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci. 1995;84:697-706.
44. Kim J. The use of vital dyes in corneal disease. Curr Opin Ophthalmol. 2000;11:241-247.
45. Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol. 2002;28:389-400.
46. Green K, Downs SJ. Corneal membrane water permeability as a function of temperature. Invest Ophthalmol. 1976;15:304-307.
47. Efron N, Young G, Brennan NA. Ocular surface temperature. Curr Eye Res. 1989;8:901-906.
48. Yamaguchi K, Barbe MF, Brown IR, et al. Induction of stress (heat shock) protein 70 and its mRNA in rat corneal epithelium by hyperthermia. Curr Eye Res. 1990;9:913-918.
49. Miller MW, Ziskin MC. Biological consequences of hyperthermia. Ultrasound Med Biol. 1989;15:707-722.
50. Silverman RH, Lizzi FL, Ursea BG, et al. Safety levels for exposure of cornea and lens to very high-frequency ultrasound. J Ultrasound Med. 2001;20:979-986.
51. Edwards MJ. Congenital defects in guinea pigs following induced hyperthermia during gestation. Arch Pathol. 1967;84:42-48.
52. Torchia RT, Purnell EW, Sokollu A. Cataract production by ultrasound. Am J Ophthalmol. 1967;64:305-309.
53. Food and Drug Administration. Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers. Rockville, MD: Center for Devices and Radiological Health, Food and Drug Administration, US Department of Health and Human Services, 1997.
54. Doughty MJ. Evaluation of the effects of saline versus bicarbonate-containing mixed salts solutions on rabbit corneal epithelium in vitro. Ophthalmic Physiol Opt. 1995;15:585-599.
55. Boucaud A, Machet L, Arbeille B, et al. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int J Pharm 2001;228:69-77.